Antibodies that specifically bind to the EphA2 receptor
US9676864B2 · kind B2 · utility
1Cited by
62References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 15, 2014 |
| Grant date | Jun 13, 2017 |
| Priority date | — |
| Expiry date | Jan 15, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to an antibody or an epitope-binding fragment thereof that specifically binds to an EphA2 receptor. It further relates to a conjugate comprising a cytotoxic agent which is covalently bound to the antibody and a method for preparing such a conjugate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.